Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-01 06:05 am Purchase | 2022-08-19 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 81,758 6.100% | 8,980 (+12.34%) | Filing History |
| 2022-08-11 10:26 am Purchase | 2022-08-09 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 72,778 5.500% | 14,441 (+24.75%) | Filing History |
| 2022-07-27 9:45 pm Purchase | 2022-07-27 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 58,337 4.400% | 6,602 (+12.76%) | Filing History |
| 2022-06-29 4:30 pm Purchase | 2022-06-22 | 13G | Pasithea Therapeutics Corp. KTTA | Paul B Manning | 170,435 9.800% | 170,435 (New Position) | Filing History |
| 2022-06-24 6:16 pm Unchanged | 2022-06-23 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 51,735 4.400% | 0 (Unchanged) | Filing History |
| 2022-06-16 10:29 am Unchanged | 2022-06-14 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 51,735 4.400% | 0 (Unchanged) | Filing History |
| 2022-06-01 10:08 am Purchase | 2022-05-22 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 51,735 4.400% | 51,735 (New Position) | Filing History |
| 2022-02-03 3:53 pm Purchase | 2021-12-31 | 13G | Brickell Biotech, Inc. BBI | Ionic Ventures, LLC | 19,339 2.850% | 2,524 (+15.01%) | Filing History |
| 2022-01-31 6:21 pm Sale | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 54,721 4.990% | -30,279 (-35.62%) | Filing History |
| 2022-01-13 10:56 am Sale | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | Alpha Capital Anstalt | 35,750 3.267% | -5,838 (-14.04%) | Filing History |
| 2021-12-20 4:00 pm Purchase | 2021-11-29 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 85,000 7.480% | 85,000 (New Position) | Filing History |
| 2021-11-04 4:02 pm Purchase | 2021-11-04 | 13G | Pasithea Therapeutics Corp. KTTA | Alpha Capital Anstalt | 41,588 6.360% | 41,588 (New Position) | Filing History |
| 2021-09-21 7:02 pm Purchase | 2021-09-21 | 13G | Brickell Biotech, Inc. BBI | Ionic Ventures, LLC | 16,815 5.800% | 16,815 (New Position) | Filing History |